BridgeBio Pharma (BBIO) Financial Statements

1,473 Followers

BridgeBio Pharma Financial Overview

BridgeBio Pharma's market cap is currently $13.89B. The company's EPS TTM is $; its P/E ratio is -20.69; BridgeBio Pharma is scheduled to report earnings on April 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 502.08M	$ 221.90M	$ 9.30M	$ 77.65M	$ 69.72M
Gross Profit	$ 473.81M	$ 218.02M	$ 6.86M	$ 74.21M	$ 66.60M
Operating Income	$ -569.09M	$ -592.97M	$ -607.37M	$ -512.20M	$ -576.63M
EBITDA	$ -672.88M	$ -436.83M	$ -565.47M	$ -397.44M	$ -533.83M
Net Income	$ -729.31M	$ -535.76M	$ -643.20M	$ -481.18M	$ -562.54M
Balance Sheet
Cash & Short-Term Investments	$ 587.48M	$ 681.10M	$ 434.88M	$ 471.92M	$ 836.66M
Total Assets	$ 936.02M	$ 919.34M	$ 546.38M	$ 623.04M	$ 1.01B
Total Debt	$ 2.73B	$ 1.73B	$ 1.74B	$ 1.72B	$ 1.73B
Net Debt	$ 2.16B	$ 1.05B	$ 1.36B	$ 1.35B	$ 1.33B
Total Liabilities	$ 3.01B	$ 2.38B	$ 1.89B	$ 1.87B	$ 1.88B
Stockholders' Equity	$ -2.08B	$ -1.47B	$ -1.35B	$ -1.25B	$ -870.41M
Cash Flow
Free Cash Flow	$ -447.01M	$ -521.66M	$ -529.03M	$ -425.81M	$ -546.18M
Operating Cash Flow	$ -445.91M	$ -520.73M	$ -527.72M	$ -419.49M	$ -497.93M
Investing Cash Flow	$ -24.49M	$ 60.78M	$ 54.03M	$ 453.15M	$ -200.83M
Financing Cash Flow	$ 359.29M	$ 748.46M	$ 451.54M	$ -13.13M	$ 736.45M

Currency in USD

BridgeBio Pharma Earnings and Revenue History

Income Statement >

BridgeBio Pharma Debt to Assets

Balance Sheet >

BridgeBio Pharma Cash Flow

Cash Flow >

BridgeBio Pharma Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >